Imbed Biosciences has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP), the company announced today. According…

Imbed Biosciences has been awarded $800,000 in a Commercialization Readiness Pilot (CRP) grant by the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the company announced today. According…

Imbed Biosciences has partnered with Spartan Medical, a company that provides an extensive portfolio of advanced medical devices and technologies from premier partners, the company announced recently. According to a…

Imbed Biosciences announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte Matrix, in complex chronic wounds. “This was a very professionally run prospective…

Imbed Biosciences announced today that it raised another $2 million in its previously closed Series A funding round, which now totals $4 million. According to release, the round, which closed…

Imbed Biosciences, a medical device company that is developing advanced therapies for soft tissue repair, has received a $1.5 million, two-year Small Business Innovation Research (SBIR) grant, the University of…

Imbed Biosciences, a medical device company that is developing advanced therapies for soft tissue repair, has closed a $2 million Series A funding round, the company announced recently. According to…